Overview

The mission of Wistar's Technology Transfer Department and Office of Business Development is to promote the commercialization of inventions discovered at Wistar for society's use and benefit while generating income to support further research and education at Wistar. Past commercial successes include monoclonal antibodies for the diagnosis and treatment of cancer and vaccines against polio, rabies, and rubella.

Wistar's licensing opportunities are separated into two categories:

• Technologies (which are primarily for the diagnosis and treatment of disease and often licensed on an exclusive basis, or are available for sponsored research support)
  
• Research Tools (which are licensed on a nonexclusive basis for research purposes)

Click on By Inventors to see licensing opportunities for a specific Wistar scientist.

The Technology Transfer Department and Office of Business Development also manages the intellectual property assets of the Institute and oversees biological material transfers.